UK Markets close in 8 hrs 9 mins

NFL Biosciences SA (ALNFL.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
2.78000.0000 (0.00%)
As of 09:05AM CET. Market open.

NFL Biosciences SA

199 Rue Helene Boucher
Castelnau-le-Lez 34170
France
33 4 11 93 76 67
http://www.nflbiosciences.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees

Description

NFL Biosciences, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.

Corporate governance

NFL Biosciences SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.